| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/24/2008 | US20080096820 Prodomain modulators of ADAM 10 |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080096210 Cancer suppressing agent |
| 04/24/2008 | US20080095869 Anticancer Treatment |
| 04/24/2008 | US20080095835 Cyclin dependent kinase inhibitors; gene expression inhibition; cell differentiation; immunotherapy; cytokines |
| 04/24/2008 | US20080095790 Methods of Treating Prostate Cancer |
| 04/24/2008 | US20080095788 Vaccines |
| 04/24/2008 | US20080095780 Binding Molecules For Treatment And Detection Of Cancer |
| 04/24/2008 | US20080095770 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 04/24/2008 | US20080095766 Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095755 Methods and compositions for the treatment of cancer |
| 04/24/2008 | US20080095746 Using cells expressing podocalyxin-like protein 1 (PCLP1) as source for propagating progenitor cells for use in treatment of blood and vascular diseases; regenerative medicine |
| 04/24/2008 | US20080095745 Transgenic butyrivibrio fibrisolvens for use in treatment and prevention of infections, allergic and inflammatory bowel disease |
| 04/24/2008 | US20080095744 Using conditionally replicative herpes viral vector comprising cytokine sequences to transform cells and activate immune response from CD4, CD8 and natural killer cells towards aberrently proliferating cells; immunotherapy |
| 04/24/2008 | US20080095707 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents |
| 04/24/2008 | US20080095700 DR4 antibodies and uses thereof |
| 04/24/2008 | DE102007006136A1 Z-Stilben-Derivate und das Arzneimittel davon Z-stilbene derivatives and pharmaceutical compositions thereof |
| 04/24/2008 | DE102006049527A1 Use of potassium voltage channel 1.5 inhibitors for producing a medicament for the therapy or prophylaxis of e.g. respiratory disorders, upper airway resistance syndrome, neurodegenerative disorders and lung cancer |
| 04/24/2008 | CA2667085A1 Incorporation of active molecules into microalga |
| 04/24/2008 | CA2667030A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | CA2666841A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 04/24/2008 | CA2666809A1 Anti-cancer agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666697A1 Block copolymer for drug conjugates and pharmaceutical composition |
| 04/24/2008 | CA2666664A1 Sulfamoyl-containing derivatives and uses thereof |
| 04/24/2008 | CA2666559A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666458A1 Antibody molecules which bind il-17a and il-17f |
| 04/24/2008 | CA2666116A1 Phenylacetamides useful as protein kinase inhibitors |
| 04/24/2008 | CA2665528A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | CA2665384A1 Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors |
| 04/24/2008 | CA2664828A1 Rspondins as modulators of angiogenesis and vasculogenesis |
| 04/24/2008 | CA2664275A1 Crystalline form phthalazinone derivative for use in cancer treatment |
| 04/24/2008 | CA2660166A1 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7 |
| 04/23/2008 | EP1914554A2 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1914243A2 Anti-CD40 monoclonal antibody |
| 04/23/2008 | EP1914237A2 Phosphonate ester antiviral compounds |
| 04/23/2008 | EP1914234A1 Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors |
| 04/23/2008 | EP1914230A1 Wortmannin analogs and methods of using same |
| 04/23/2008 | EP1913958A1 Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab |
| 04/23/2008 | EP1913947A1 Combination therapy for the treatment of cancer |
| 04/23/2008 | EP1913398A2 Treatment of proliferative disorders |
| 04/23/2008 | EP1913152A2 Identification of compounds modulating the smyd3 transferase for the treatment of cancer |
| 04/23/2008 | EP1912998A1 Pyrazole derivatives having tyrosinkinase activity |
| 04/23/2008 | EP1912994A1 Adenine derivatives |
| 04/23/2008 | EP1912988A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 04/23/2008 | EP1912987A1 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| 04/23/2008 | EP1912982A2 Novel heterocyclic nf- b inhibitors |
| 04/23/2008 | EP1912973A2 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 04/23/2008 | EP1912972A1 Substituted imidazole compounds as ksp inhibitors |
| 04/23/2008 | EP1912969A1 Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
| 04/23/2008 | EP1912964A2 Dihydroxyanthraquinones and their use |
| 04/23/2008 | EP1912954A2 Novel cysteine protease inhibitors and their therapeutic applications |
| 04/23/2008 | EP1912932A2 Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators |
| 04/23/2008 | EP1912921A2 Tetraazaporphyrin-based compounds and their uses |
| 04/23/2008 | EP1912678A2 Use of an active biological substance in abnormal cellular and viral membrane physiologies |
| 04/23/2008 | EP1912677A2 Psma antibody-drug conjugates |
| 04/23/2008 | EP1912675A2 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 04/23/2008 | EP1912658A1 Therapeutic protocols using hyaluronan |
| 04/23/2008 | EP1912652A1 TREATMENT OF TUMOURS WITH IKK-ß INHIBITORS |
| 04/23/2008 | EP1912646A2 Combinations containing ikk-beta inhibitors |
| 04/23/2008 | EP1912640A1 Use of hdac inhibitors for the treatment of myeloma |
| 04/23/2008 | EP1912635A2 Use of chk2 kinase inhibitors for cancer treatment |
| 04/23/2008 | EP1699822B1 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 04/23/2008 | EP1618117B1 Tumor selective and biodegradable polyphosphazene-platinum(ii) conjugate antitumor agent, and preparation method thereof |
| 04/23/2008 | EP1534716B1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1422243B1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1251871B1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and as adjuvants an immunogenic oligodeoxynucleotide and a polycationic polypeptide |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1214398B1 Chimeric virus-like particles or chimeric capsomers from bpv |
| 04/23/2008 | EP0804212B1 Nigella sativa as a medicinal treatment |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166760A A molecule and chimeric molecules thereof |
| 04/23/2008 | CN101166759A T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
| 04/23/2008 | CN101166739A Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof |
| 04/23/2008 | CN101166732A Cyanopyridine derivative and use thereof as medicine |
| 04/23/2008 | CN101166528A Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (PEG2) |
| 04/23/2008 | CN101165068A Monoclonal antibody for resisting HER2/ErbB2 antigen, preparation method and medicament composition thereof |
| 04/23/2008 | CN101165066A Protankyra bidentata anti-tumor factor and its composition, preparation method and application |
| 04/23/2008 | CN101165063A Meliacarpinin derivatives, preparation method and use thereof |
| 04/23/2008 | CN101165037A Beta-elemene monosubstituted ether derivatives, synthesis method and use thereof |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164624A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 04/23/2008 | CN101164616A Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 04/23/2008 | CN101164558A Clot-dispersing pain-relieving medicinal composition and preparation method and application thereof |
| 04/23/2008 | CN101164552A Centipede polysaccharide protein anti-tumor capsule and preparation method |
| 04/23/2008 | CN101164551A Optimization formula for liver cancer-resisting traditional Chinese medicine active ingredient |
| 04/23/2008 | CN101164548A Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 04/23/2008 | CN101164536A Apigenin vesicle preparation and its preparation technology |
| 04/23/2008 | CN101164534A Application of curcumin in preparing tumor multi-medicine drug-resistant prevention agent |
| 04/23/2008 | CN101164533A Use of ultrasound contrast agent |
| 04/23/2008 | CN100383161C Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application |
| 04/23/2008 | CN100383157C 3beta, 5 alpha, 6 beta, 11 beta tetrahydroxy cholestanol, and its preparing method and use |